| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gary Charles Robb | CXO | 2026-09-17 | 17,493 | $8.27 | $144.67kBuy |
| Roberto Wandenkolk Vieira | Pres | 2026-09-16 | 296 | $100.82 | $29.84kSell |
| James N. Wilson | Director | 2026-09-15 | 400 | $110.84 | $44.33kSell |
| James N. Wilson | Director | 2026-09-15 | 6,800 | $110.27 | $749.84kSell |
| James N. Wilson | Director | 2026-09-15 | 2,800 | $111.70 | $312.77kSell |
| Joseph Douglas Lyon | CTO;CAO | 2026-09-14 | 2,188 | $114.12 | $249.69kSell |
| Joseph Douglas Lyon | CTO;CAO | 2026-09-14 | 2,596 | $11.35 | $29.46kBuy |
| Joseph Douglas Lyon | CTO;CAO | 2026-09-14 | 7,404 | $13.56 | $100.40kBuy |
| Joseph Douglas Lyon | CTO;CAO | 2026-09-14 | 7,812 | $113.32 | $885.26kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 5,621 | $114.58 | $644.04kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick G. Enright | 41.45% | 44,802,403 | $4.94B | Insider |
| Bakker Juliet Tammenoms | 10.26% | 11,089,541 | $1.22B | Insider |
| Longitude Venture Partners LP | 10.14% | 10,956,002 | $1.21B | Insider |
| Alta Biopharma Partners II LP | 9.23% | 9,982,720 | $1.10B | Insider |
| G. Leonard Baker Jr. | 8.73% | 9,440,067 | $1.04B | Insider |
| Tench Coxe | 6.37% | 6,890,503 | $759.95M | Insider |
| Joseph C. Cook Jr. | 6.26% | 6,765,805 | $746.20M | Insider |
| David L. Anderson | 5.94% | 6,420,729 | $708.14M | Insider |
| William H. Younger Jr. | 5.88% | 6,353,537 | $700.73M | Insider |
| Joseph K. Belanoff | 5.78% | 6,248,596 | $689.16M | Insider |